Spots Global Cancer Trial Database for endometrial serous adenocarcinoma

Every month we try and update this database with for endometrial serous adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer	NCT03836157	Endometrial Can... Endometrial Ade... Endometrial Ser... Endometrial Cle...	Mirvetuximab So... Bevacizumab	18 Years -	University of Oklahoma
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer	NCT00005840	Endometrial Cle... Endometrial Ser... Stage III Uteri... Stage IV Uterin...	Paclitaxel Cisplatin Radiation Thera...	18 Years -	GOG Foundation
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer	NCT00005830	Endometrial Ade... Endometrial Cle... Endometrial Ser... Stage III Uteri... Stage IV Uterin...	Doxorubicin Hyd... Cisplatin Radiation Thera...	18 Years -	GOG Foundation
Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer	NCT02728258	Endometrial End... Endometrial Mix... Endometrial Ser... Endometrial Und... Metastatic Endo... Recurrent Uteri...	Copanlisib Laboratory Biom...	18 Years -	NRG Oncology
AMT-151 in Patients With Selected Advanced Solid Tumours	NCT05498597	Advanced Solid ... Advanced Cancer Advanced Carcin... Ovarian Cancer Ovarian Carcino... Ovarian Epithel... Ovarian Endomet... Endometrial Can... Endometrial Ade... Endometrial Ser... Endometrial End... Endometrial Cle... Lung Adenocarci... Triple Negative... Pancreatic Duct... Malignant Pleur... Ovarian Clear C... Ovarian Clear C... Ovarian Mucinou...	AMT-151	18 Years -	Multitude Therapeutics Inc.
Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer	NCT01010126	Adult Hepatocel... Advanced Adult ... Endometrial Ser... Localized Non-R... Lung Carcinoid ... Malignant Pancr... Malignant Pancr... Malignant Pancr... Malignant Pancr... Metastatic Dige... Ovarian Carcino... Ovarian Endomet... Ovarian Seromuc... Ovarian Serous ... Pancreatic Alph... Pancreatic Beta... Pancreatic Delt... Pancreatic G-Ce... Pancreatic Poly... Recurrent Adult... Recurrent Diges... Recurrent Fallo... Recurrent Ovari... Recurrent Pancr... Recurrent Prima... Recurrent Uteri... Regional Digest... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIA Uter... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIB Uter... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IIIC Uter... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IVA Uteri... Stage IVB Uteri... Uterine Carcino...	Bevacizumab Temsirolimus	18 Years -	National Cancer Institute (NCI)
Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer	NCT01935934	Endometrial Ade... Endometrial Cle... Endometrial Mix... Endometrial Ser... Metastatic Endo... Recurrent Uteri... Stage IV Uterin... Stage IVA Uteri... Stage IVB Uteri... Uterine Corpus ...	Cabozantinib S-... Laboratory Biom... Pharmacological...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer	NCT00005840	Endometrial Cle... Endometrial Ser... Stage III Uteri... Stage IV Uterin...	Paclitaxel Cisplatin Radiation Thera...	18 Years -	GOG Foundation
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer	NCT03422198	Endometrial Cle... Endometrial End... Endometrial Ser... Stage I Uterine... Stage IA Uterin... Stage IB Uterin... Stage II Uterin... Uterine Corpus ... Uterine Corpus ...	Vaginal Cuff Br... Short course va...	-	University of Utah
Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer	NCT01005329	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Ser... Stage IA Uterin... Stage IB Uterin... Stage II Uterin... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri...	Bevacizumab Carboplatin Cisplatin Intensity-Modul... Paclitaxel	18 Years -	National Cancer Institute (NCI)
Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer	NCT01440998	Endometrial Ade... Endometrial Cle... Endometrial Muc... Endometrial Ser... Endometrial Squ... Endometrial Tra... Endometrial Und... Endometrioid Ad... Recurrent Uteri... Stage III Uteri... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IV Uterin... Stage IVA Uteri... Stage IVB Uteri...	Carboplatin Dasatinib Laboratory Biom... Paclitaxel	18 Years -	National Cancer Institute (NCI)
Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT01225887	Endometrial Ade... Endometrial Cle... Endometrial Muc... Endometrial Ser... Endometrial Squ... Endometrial Tra... Endometrial Und... Malignant Uteri... Recurrent Uteri...	Nintedanib	18 Years -	GOG Foundation
Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT01642082	Endometrial Ade... Endometrial Cle... Endometrial Mix... Endometrial Muc... Endometrial Ser... Endometrial Squ... Endometrial Tra... Endometrial Und... Recurrent Uteri...	Dalantercept Laboratory Biom...	18 Years -	GOG Foundation
Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer	NCT02874430	Breast Carcinom... Endometrial Cle... Endometrial Ser... Uterine Corpus ... Uterine Corpus ...	Metformin Hydro... Doxycycline	18 Years -	Thomas Jefferson University
TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors	NCT02142803	Adult Glioblast... Endometrial Cle... Endometrial Ser... Ovarian Clear C... Ovarian Endomet... Ovarian Mucinou... Ovarian Serous ... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Recurrent Uteri... Solid Neoplasm Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar...	Bevacizumab Laboratory Biom... Pharmacological... Sapanisertib	18 Years -	National Cancer Institute (NCI)
Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer	NCT02112552	Endometrial Ser... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC1 Ute... Stage IIIC2 Ute... Stage IVA Uteri... Stage IVB Uteri...	Paclitaxel Carboplatin 3-Dimensional C... Intensity-Modul... Quality-of-Life... Laboratory Biom...	18 Years -	Albert Einstein College of Medicine
Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer	NCT00478426	Endometrial Ade... Endometrial End... Endometrial Ser... Recurrent Uteri... Stage IVA Uteri... Stage IVB Uteri... Uterine Carcino... Uterine Corpus ...	Sunitinib Malat...	18 Years -	National Cancer Institute (NCI)
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in High-Risk Endometrial Cancers	NCT05049538	Endometrial Cle... Endometrial Ded... Endometrial Muc... Endometrial Ser... Malignant Uteri... Uterine Corpus ...	Biospecimen Col... Liquid Biopsy Pap Smear	18 Years -	M.D. Anderson Cancer Center
Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT00888173	Endometrial Ade... Endometrial Cle... Endometrial Mix... Endometrial Muc... Endometrial Ser... Endometrial Squ... Endometrial Tra... Endometrial Und... Recurrent Uteri...	Brivanib Alanin... Laboratory Biom...	18 Years -	GOG Foundation
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery	NCT02315469	Endometrial Ser... Fallopian Tube ... Malignant Femal... Ovarian Carcino... Primary Periton... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri...	Comprehensive G... Questionnaire A...	70 Years -	NRG Oncology
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer	NCT03914612	Endometrial Cle... Endometrial Ded... Endometrial End... Endometrial Mix... Endometrial Ser... Endometrial Und... Recurrent Endom... Recurrent Endom... Recurrent Endom... Recurrent Endom... Recurrent Endom... Recurrent Endom... Recurrent Endom... Recurrent Endom... Stage III Uteri... Stage IV Uterin...	Carboplatin Computed Tomogr... Paclitaxel Pembrolizumab Placebo Adminis... Quality-of-Life... Questionnaire A...	18 Years -	National Cancer Institute (NCI)
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery	NCT02315469	Endometrial Ser... Fallopian Tube ... Malignant Femal... Ovarian Carcino... Primary Periton... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri...	Comprehensive G... Questionnaire A...	70 Years -	NRG Oncology
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in High-Risk Endometrial Cancers	NCT05049538	Endometrial Cle... Endometrial Ded... Endometrial Muc... Endometrial Ser... Malignant Uteri... Uterine Corpus ...	Biospecimen Col... Liquid Biopsy Pap Smear	18 Years -	M.D. Anderson Cancer Center
TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors	NCT02142803	Adult Glioblast... Endometrial Cle... Endometrial Ser... Ovarian Clear C... Ovarian Endomet... Ovarian Mucinou... Ovarian Serous ... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Recurrent Uteri... Solid Neoplasm Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar...	Bevacizumab Laboratory Biom... Pharmacological... Sapanisertib	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer	NCT00005830	Endometrial Ade... Endometrial Cle... Endometrial Ser... Stage III Uteri... Stage IV Uterin...	Doxorubicin Hyd... Cisplatin Radiation Thera...	18 Years -	GOG Foundation
Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT01935973	Endometrial Ade... Endometrial Cle... Endometrial Mix... Endometrial Ser... Endometrial Und... Recurrent Uteri...	Laboratory Biom... Trametinib Uprosertib	18 Years -	National Cancer Institute (NCI)
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Endometrial Cancer	NCT04585958	Endometrial Ser... Metastatic Mali... Unresectable Ma...	Biopsy Biospecimen Col... Computed Tomogr... Echocardiograph... Olaparib Trastuzumab Der...	18 Years -	National Cancer Institute (NCI)
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Endometrial Cancer	NCT04585958	Endometrial Ser... Metastatic Mali... Unresectable Ma...	Biopsy Biospecimen Col... Computed Tomogr... Echocardiograph... Olaparib Trastuzumab Der...	18 Years -	National Cancer Institute (NCI)
Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone	NCT03660826	Endometrial Ade... Endometrial Mix... Endometrial Ser... Endometrial Und... Endometrioid Ad... Stage IV Uterin...	Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Capivasertib Cediranib Cediranib Malea... Computed Tomogr... Durvalumab Echocardiograph... Multigated Acqu... Olaparib	18 Years -	National Cancer Institute (NCI)
Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer	NCT01344837	Endometrial Ser... Stage I Uterine... Stage II Uterin... Stage III Uteri... Stage IV Uterin...	Diagnostic Labo... Immunohistochem... Medical Chart R... Microarray Anal... Study of Socioe... Western Blottin...	-	GOG Foundation
Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer	NCT01935934	Endometrial Ade... Endometrial Cle... Endometrial Mix... Endometrial Ser... Metastatic Endo... Recurrent Uteri... Stage IV Uterin... Stage IVA Uteri... Stage IVB Uteri... Uterine Corpus ...	Cabozantinib S-... Laboratory Biom... Pharmacological...	18 Years -	National Cancer Institute (NCI)
Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer	NCT02728258	Endometrial End... Endometrial Mix... Endometrial Ser... Endometrial Und... Metastatic Endo... Recurrent Uteri...	Copanlisib Laboratory Biom...	18 Years -	NRG Oncology
Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer	NCT01005329	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Ser... Stage IA Uterin... Stage IB Uterin... Stage II Uterin... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri...	Bevacizumab Carboplatin Cisplatin Intensity-Modul... Paclitaxel	18 Years -	National Cancer Institute (NCI)
Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer	NCT00006011	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial End... Endometrial Ser... Stage III Uteri...	Doxorubicin Hyd... Cisplatin Filgrastim Pegfilgrastim Paclitaxel	-	GOG Foundation
Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol	NCT02501954	Endometrial Cle... Endometrial Ser... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri...	Cisplatin Carboplatin Paclitaxel Radiation Thera...	18 Years -	Women's Cancer Care Associates, LLC
Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer	NCT00575952	Endometrial Ade... Endometrial Cle... Endometrial Mix... Endometrial Ser... Endometrial Squ... Endometrial Und... Recurrent Uteri... Stage IIIA Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri...	Cisplatin Doxorubicin Hyd... Filgrastim Paclitaxel Pegfilgrastim	-	GOG Foundation
Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT01132820	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Ser... Recurrent Uteri...	Cediranib Malea... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer	NCT03836157	Endometrial Can... Endometrial Ade... Endometrial Ser... Endometrial Cle...	Mirvetuximab So... Bevacizumab	18 Years -	University of Oklahoma
Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy	NCT04494113	Endometrial Ser...	Biopsy Biospecimen Col... Resection Triapine	18 Years -	National Cancer Institute (NCI)
Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone	NCT03660826	Endometrial Ade... Endometrial Mix... Endometrial Ser... Endometrial Und... Endometrioid Ad... Stage IV Uterin...	Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Capivasertib Cediranib Cediranib Malea... Computed Tomogr... Durvalumab Echocardiograph... Multigated Acqu... Olaparib	18 Years -	National Cancer Institute (NCI)
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer	NCT00807768	Endometrial Cle... Endometrial Ser... Fatigue Neurotoxicity S... Obesity Stage I Uterine... Stage II Uterin...	3-Dimensional C... Carboplatin Intensity-Modul... Internal Radiat... Laboratory Biom... Paclitaxel Quality-of-Life... Questionnaire A...	18 Years -	GOG Foundation
Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy	NCT04494113	Endometrial Ser...	Biopsy Biospecimen Col... Resection Triapine	18 Years -	National Cancer Institute (NCI)
Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer	NCT01005329	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Ser... Stage IA Uterin... Stage IB Uterin... Stage II Uterin... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri...	Bevacizumab Carboplatin Cisplatin Intensity-Modul... Paclitaxel	18 Years -	National Cancer Institute (NCI)
Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer	NCT01307631	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Ser... Recurrent Uteri...	Akt Inhibitor M... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer	NCT00942357	Endometrial Cle... Endometrial Ser... Stage IA Uterin... Stage IB Uterin... Stage II Uterin... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri...	Carboplatin Cisplatin Internal Radiat... Paclitaxel Quality-of-Life... Radiation Thera...	18 Years -	GOG Foundation
Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer	NCT01210222	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial End... Endometrial Ser... Endometrioid St... Recurrent Uteri...	Trebananib	18 Years -	GOG Foundation
Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer	NCT00977574	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Ser... Recurrent Uteri... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri...	Bevacizumab Carboplatin Ixabepilone Laboratory Biom... Paclitaxel Temsirolimus	18 Years -	National Cancer Institute (NCI)
Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer	NCT00006011	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial End... Endometrial Ser... Stage III Uteri...	Doxorubicin Hyd... Cisplatin Filgrastim Pegfilgrastim Paclitaxel	-	GOG Foundation
Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers	NCT02020707	Cervical Adenoc... Cervical Adenos... Cervical Adenos... Cervical Carcin... Cervical Squamo... Clinical Stage ... Endometrial Ade... Endometrial Cle... Endometrial End... Endometrial Mix... Endometrial Muc... Endometrial Ser... Endometrial Und... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Malignant Femal... Malignant Ovari... Malignant Ovari... Malignant Ovari... Malignant Ovari... Malignant Perit... Malignant Solid... Ovarian Carcino... Ovarian Clear C... Ovarian Endomet... Ovarian High Gr... Ovarian Mucinou... Ovarian Serous ... Ovarian Transit... Ovarian Undiffe... Platinum-Resist... Platinum-Resist... Platinum-Resist... Platinum-Sensit... Primary Periton... Primary Periton... Primary Periton... Primary Periton... Primary Periton... Unresectable Me... Uterine Corpus ...	Bevacizumab Laboratory Biom... Nab-paclitaxel Pharmacological...	18 Years -	Mayo Clinic

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: